Monroe MRCC Delivers Q4 2025 Beat EPS 011 vs 009 Expected Consumer Prices Rise 38 Annually in April Marking Fastest Pace Since Mid2023 Immuneering Reports Q1 2026 Financial Results Highlights Promising Pancreatic Cancer Data Ahead of ASCO 2026 NHPAP Preferred Stock Holds Steady Near Support as Volume Remains Subdued Humanoid Robots Draw Attention at Japan Trade Show Signaling Potential Industry Growth OPCH Q1 2026 Earnings Profit Beat Offsets Revenue Uncertainty Meta Launches First AI Subscription Expanding Paid Services for Instagram and Facebook